Q2 FY2026 · ended Jun 30, 2026 · Revenue $88,626, +2136.9% YoY · Filed Aug 13, 2026
TAO Synergies Inc. (TAOX) files with the SEC under industry code 6199, Finance Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $88,626 and a net loss of $9.3 million.
Revenue
$88,626
+2136.9% vs year-ago quarter
Net income
$-9.30M
+46.9% vs year-ago quarter
Operating cash flow
$-874,981
-16.8% vs year-ago quarter
Free cash flow
—
EPS
$-1.83
+83.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
7.48M
+114.6% vs year-ago quarter
Net cash
—
Operating margin
-1013.5%
TTM
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- TAOX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1571934
- Former names
- Synaptogenix, Inc. (until Jun 24, 2025); NEUROTROPE BIOSCIENCE, INC. (until Nov 20, 2020)
Other Finance Services companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $88,626 | $388,774 | $91,728 | $203,371 | $3,962 |
| Operating income | -$1.6M | -$1.3M | -$3.1M | -$1.8M | -$3.0M |
| Net income | -$9.3M | $4.3M | -$7.7M | -$3.9M | -$17.5M |
| Diluted EPS | -$1.83 | $0.43 | -$1.17 | -$1.56 | -$11.26 |
| Operating cash flow | -$874,981 | -$1.7M | -$2.5M | -$1.2M | -$749,072 |
| Total assets | $21.1M | $31.0M | $25.8M | $18.4M | $19.8M |
| Total liabilities | $3.8M | $4.9M | $3.9M | $1.7M | $1.8M |
| Stockholders' equity | $12.7M | $23.3M | $21.1M | $16.1M | $17.2M |
| Cash and investments | $2.4M | $3.6M | $5.5M | — | $14.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-K/A | Amended annual report | Jun 5, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 19, 2025 | Dec 18, 2025 |
| ARS | Annual report to shareholders | Nov 17, 2025 | Dec 31, 2024 |
All 243 TAO Synergies Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.